AzTrials
AzTrials

Colorectal PolypNCT04831814

Narrow Band Imaging in Diagnosis of Colorectal Polyps

A study testing Near Focus NBI and Standard Focus NBI in people with Colorectal Polyp and Colorectal Neoplasms, run by Prince of Songkla University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Optical diagnosis of colorectal polyps is a promising tool to avoid risks of unnecessary polypectomies and to save costs of tissue pathology. NICE (NBI International Colorectal Endoscopic) and WASP (Workgroup on Serrated Polyps and Polyposis) classification were developed for diagnosis of adenomatous and sessile… Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Colorectal Polyp, Colorectal Neoplasms
What is being tested?
Near Focus NBI and Standard Focus NBI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
118 participants
Where
1 siteThailand
Study dates
4 Apr 2019to 14 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who were scheduled for colonoscopy at NKC institute

Who cannot join

  • Inflammatory bowel disease
  • Polyposis syndrome
  • Colorectal cancer
  • Active gastrointestinal bleeding
  • Pregnant woman
  • Inadequate bowel preparation
  • Contraindication for polyps removal

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Prince Songkla University

    Hat Yai, Changwat Songkhla, 90110

Other trials in Thailand

About this study

Official title: Near-focus Versus Normal-focus Narrow Band Imaging Colonoscopy in Diagnosis of Colorectal Polyps Based on Combined NICE and WASP Classification: a Randomized Controlled Trial

Optical diagnosis of colorectal polyps is a promising tool to avoid risks of unnecessary polypectomies and to save costs of tissue pathology. NICE (NBI International Colorectal Endoscopic) and WASP (Workgroup on Serrated Polyps and Polyposis) classification were developed for diagnosis of adenomatous and sessile serrated polyps, respectively.

Read the detailed description

Near-focus (NF) narrow-band imaging (NBI) is an image-magnifying technology which enables optical magnification of up to 65x in near focus (NF) compared with 52x in normal standard focus (SF) with the simple push of a button of the endoscope to be interchangeable between NF and SF. There were few studies comparing diagnostic accuracy between NF and SF in the diagnosis of colorectal polyps. So, our aim of the current study is to compare accuracy of NF NBI compared with SF NBI in the optical diagnosis of neoplastic and non-neoplastic polyp and the accuracy of NF NBI versus SF NBI in distinguishing serrated adenoma from hyperplastic polyp in sessile lesions using histologic evaluation as the gold standard.

Being tested
Near Focus NBI, Standard Focus NBI
Medical subject headings
Colorectal Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Near Focus NBIDiagnostic test

    Colonoscopy with near focus narrowing band imaging technology . Optical specifications include a 2 mm near field focal depth. Optical diagnosis of polyps were according to NICE and WASP, respectively.

  • Standard Focus NBIDiagnostic test

    Colonoscopy with narrow band imaging technology.Optical diagnosis of polyps were according to NICE and WASP, respectively.

Study groups in NCT04831814
Study groupRoleWhat they receive
Near Focus NBIExperimentalUse of the Near Focus NBI to make optical diagnosis
Receives: Diagnostic Test: Near Focus NBI
Standard Focus NBIActive comparatorUse of the Standard Focus NBI to make optical diagnosis
Receives: Diagnostic Test: Standard Focus NBI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of accurate polyp histology predictions by the Endoscopists in the two groups.

    Measure of the percentage of accurate predictions by the endoscopists in the differentiation of neoplastic from non neoplastic colorectal lesions, using the high definition NBI colonoscopy with and without near focus features

    Measured: At the time of procedure

  2. Rate of accurate diagnosis of sessile serrated polyps/adenoma by the Endoscopists in the two groups.

    Measure of the percentage od accurate predictions by the endoscopists in the differentiation of sessile serrated polyps/adenoma from hyperplastic polyps, using the high definition NBI colonoscopy with and without near focus features.

    Measured: At the time of procedure

Secondary outcomes (3)
  1. The polyp detection rate

    The prevalence of patients with at least one polyp was detected

    Measured: At the time of procedure

  2. The adenoma detection rate

    The prevalence of patients with at least one adenoma was detected

    Measured: At the time of procedure

  3. Diagnostic Characteristics

    Compare the diagnostic characteristic (sensitivity, specificity, positive predictive value and negative predictive value) using the high definition narrow band imaging colonoscopy with and without near focus features.

    Measured: At the time of procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2021
  2. Study start4 Apr 2019
  3. Primary completion2 Jul 2020
  4. Study completion14 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
118 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04831814
Sponsor's protocol ID
61355143
Status last verified
Mar 2021
First submitted
1 Apr 2021
Last updated
12 May 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Near Focus NBI and Standard Focus NBI in people with Colorectal Polyp and Colorectal Neoplasms, run by Prince of Songkla University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of accurate polyp histology predictions by the Endoscopists in the two groups. (time frame: At the time of procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in